Загрузка...
SGLT2 inhibition and kidney protection
Type 2 diabetes mellitus (T2DM) is a growing public health concern worldwide. Numerous drug classes are available for treatment, however, their efficacy with regard to diabetes-induced renal and cardiovascular (CV) complications remains limited. Inhibitors of the sodium-glucose cotransporter 2 (SGLT...
Сохранить в:
| Опубликовано в: : | Clin Sci (Lond) |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6648703/ https://ncbi.nlm.nih.gov/pubmed/29954951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/CS20171298 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|